about
Treatment of complex regional pain syndrome type I with bisphosphonatesWater-soluble polymer-drug conjugates for combination chemotherapy against visceral leishmaniasis.Novel Radiolabeled Bisphosphonates for PET Diagnosis and Endoradiotherapy of Bone MetastasesStrontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosisOptimizing bone health and minimizing skeletal morbidity in men with prostate cancerMolecular mechanisms of crystallization impacting calcium phosphate cements.Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient.Clinical efficacy and safety of pamidronate therapy on bone mass density in early post-renal transplant period: a meta-analysis of randomized controlled trials.Bisphosphonate-related osteonecrosis of jaw (BRONJ): diagnostic criteria and possible pathogenic mechanisms of an unexpected anti-angiogenic side effectFemoral Shaft Cortical Pathology associated with longterm Alendronate Therapy: A New ClassificationAtypical femoral fracturesSystematic review on the incidence of bisphosphonate related osteonecrosis of the jaw in children diagnosed with osteogenesis imperfecta.Can bisphosphonates play a role in the treatment of children with chronic kidney disease?Osteoporosis update.Animal models for bisphosphonate-related osteonecrosis of the jaws--an appraisal.Bisphosphonates in the management of thalassemia-associated osteoporosis: a systematic review of randomised controlled trials.Bisphosphonate-related osteonecrosis of the jaw: specificities.Osteoporosis and cardiovascular disease: an update.Neuroprotective Effects of Etidronate and 2,3,3-Trisphosphonate Against Glutamate-Induced Toxicity in PC12 Cells.Children and adolescents treated with neridronate for osteogenesis imperfecta show no evidence of any osteonecrosis of the jaw.Role of Periapical Diseases in Medication-Related Osteonecrosis of the Jaws.Low-energy conformers of pamidronate and their intramolecular hydrogen bonds: a DFT and QTAIM study.Modulation of bone turnover in orchidectomized rats treated with raloxifene and risedronate.Synthesis and biological evaluation of bisphosphonate compound labeled with (99m)Tc(CO)3(+).Differences in otosclerotic and normal human stapedial osteoblast properties are normalized by alendronate in vitro.Spatiotemporally Controlled Release of Rho-Inhibiting C3 Toxin from a Protein-DNA Hybrid Hydrogel for Targeted Inhibition of Osteoclast Formation and Activity.Safety and efficacy of hydroxyapatite scaffold in the prevention of jaw osteonecrosis in vivo.Residual effect after oral bisphosphonate treatment and healthy adherer effects--the Swedish Adherence Register Analysis (SARA).Low-magnitude high-frequency vibration (LMHFV) enhances bone remodeling in osteoporotic rat femoral fracture healing.The Potential of Probiotics as a Therapy for Osteoporosis.Treatment options for osteogenesis imperfecta
P2860
Q26777904-EBD13FB9-8E98-4139-BEC8-88BCC59FADCCQ33823803-E288C100-294D-4B4D-B613-637486335D52Q33851523-36B01AA8-B4AC-4AA8-95DB-83B90DF7B339Q34014578-F7477C07-4C66-43D3-B3E9-CD2D4EC1596BQ34023510-62266546-8998-45E1-B1C7-769C5AE57701Q34150056-E4C998DF-4645-43B1-BFEA-54466E246E4AQ34244877-80E80D40-6450-4073-A012-251438B82F17Q34269100-D8ED6B01-4AD6-4AB6-8028-7B0CE19366A8Q34322430-4BE09F05-0F34-4631-A5D5-A4B98BCE95D4Q35123236-BAE5826C-AB34-429B-A308-A00E35B2CF3BQ37008039-8F9C6866-3284-44AE-99F5-30570FCB343EQ37524684-5D7ABB32-896D-434E-A72E-A658D1C8250CQ37832414-92FC32A9-BF5F-475F-B533-D599B83F7F88Q37953523-CC694780-2415-4E67-A4A6-4F210C8C818FQ38076462-E83B2414-5D73-4671-A30E-D89953311A7BQ38205707-811FFC5C-8144-4F2B-BB50-D703D8C93882Q38493204-1FA61569-200A-4631-ACFC-419450BBB33DQ38513410-3CA37CE7-ACE4-4FF0-A5B9-62EDB62AD3D8Q38820132-E7CAFE18-1D3E-4BCA-964B-BCF2F9E48905Q39689325-4873C147-EF72-4A2A-A64D-E675A60CD9BDQ43112885-1D7E4762-BA34-4D49-91A8-E72E8112A0C4Q44946245-7D17CED9-5851-4805-9CDB-5C28F0A07342Q44959484-CEFFB3D8-DFD7-4016-AAD7-6655D25416B4Q45587240-18BC0B3D-AE53-4257-A411-920833CD4948Q46283921-D8E800C8-8F1D-444D-9D42-CBF00211D192Q47863891-AC5199DE-7ECA-40AE-B524-720DC55AF1E3Q50119706-DCEA3896-2303-4341-B2C6-14F15CEF6D3BQ50629864-E618ABC2-C50B-41F7-A850-E14486CB0401Q51487076-F3B071A3-625A-41DC-87B7-1CC62D566637Q51800938-D8C49D5D-0ABA-4ABB-8D13-2D31E3F4DFABQ58752199-4A8F00C6-D9F5-46B3-8623-BB21FF917BE3
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bisphosphonates: how do they work?
@en
Bisphosphonates: how do they work?
@nl
type
label
Bisphosphonates: how do they work?
@en
Bisphosphonates: how do they work?
@nl
prefLabel
Bisphosphonates: how do they work?
@en
Bisphosphonates: how do they work?
@nl
P1476
Bisphosphonates: how do they work?
@en
P2093
Socrates E Papapoulos
P304
P356
10.1016/J.BEEM.2008.07.001
P577
2008-10-01T00:00:00Z